Alexandria Company for Pharmaceuticals and Chemical Industries (AXPH) Financials
Annual financial statement highlights for Alexandria Company for Pharmaceuticals and Chemical Industries covering fiscal years 2006–2020. Figures are updated weekly.
| Fiscal year | Revenue | Net income | EPS | Free cash flow | Total assets | Total debt | Dividend per share |
|---|---|---|---|---|---|---|---|
| 2020ended Jun 2020 | 1.02B | 173.83M | 34.77 | 77.44M | 805.28M | 7.84M | 15.50 |
| 2019ended Jun 2019 | 829.04M | 112.85M | 22.57 | 135.24M | 689.45M | 2.42M | 11.20 |
| 2018ended Jun 2018 | 708.79M | 118.21M | 23.64 | 49.83M | 592.92M | 9.78M | 9.00 |
| 2017ended Jun 2017 | 516.94M | 91.22M | 18.24 | 17.72M | 547.31M | 4.76M | 7.50 |
| 2016ended Jun 2016 | 424.96M | 71.92M | 14.38 | 77M | 446.65M | 9.97M | 6.30 |
| 2015ended Jun 2015 | 382.89M | 59.45M | 11.89 | 12.57M | 384.95M | 1.71M | 5.50 |
| 2014ended Jun 2014 | 311.83M | 47.76M | 9.55 | 43.74M | 348.86M | 3.78M | 4.05 |
| 2013ended Jun 2013 | 292.58M | 47.88M | 9.58 | 27.26M | 325.52M | 1.26M | 4.41 |
| 2012ended Jun 2012 | 266.57M | 44.36M | 8.87 | 6.78M | 304.88M | 0 | 4.05 |
| 2011ended Jun 2011 | 229.75M | 47.36M | 9.47 | 72.82M | 296.75M | 0 | 4.95 |
| 2010ended Jun 2010 | 214.61M | 46.66M | 9.33 | 48.33M | 284.16M | 0 | 5.22 |
| 2009ended Jun 2009 | 206.72M | 48.53M | 9.70 | 33.75M | 264.63M | 0 | 5.13 |
| 2008ended Jun 2008 | 213.12M | 48.01M | 9.60 | 46.32M | 252.37M | 0 | 1.95 |
| 2007ended Jun 2007 | 208.22M | 41.71M | 8.34 | 39.27M | 244.16M | 0 | 4.87 |
| 2006 | 211.9M | 31.24M | — | 76.58M | 242.98M | 0 | 2.00 |
All figures in EGP, as reported in the company’s annual results; updated weekly.